[Bendamustine plus rituximab as first-line treatment in patients with indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma : a real-world study in China].
作者信息
Du K X, Shen H R, Wang L, Liang J H, Wu J Z, Li Y, Xia Y, Yin H, Li J Y, Xu W
机构信息
The First Affiliated Hospital of Nanjing Medical University (Department of Hematology, Jiangsu Province Hospital), Nanjing 210029, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2023 Apr 14;44(4):333-336. doi: 10.3760/cma.j.issn.0253-2727.2023.04.012.
Abstract
摘要
Zotero 插件